(VIANEWS) – Shares of Arcturus Therapeutics (NASDAQ Composite: ARCT) rose 7.27% to $33.48 at 18:02 EST on Friday, after three consecutive sessions in a row of losses. NASDAQ Composite is jumping 0.05% to $14,942.83, following the last session’s downward trend. This seems, at the moment, a somewhat bullish trend trading session today.
Arcturus Therapeutics’s last close was $31.21, 74.83% below its 52-week high of $124.00.
Today’s last reported volume for Arcturus Therapeutics is 481064 which is 17.52% below its average volume of 583284.
Arcturus Therapeutics’s Sales
Arcturus Therapeutics’s sales growth is 625.3% for the current quarter and 1814.2% for the next. The company’s growth estimates for the present quarter is a negative 72.8% and positive 6.4% for the next.
Arcturus Therapeutics’s Revenue
Year-on-year quarterly revenue growth declined by 13.8%, now sitting on 8.7M for the twelve trailing months.
Arcturus Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.13%, a positive 0.75%, and a positive 3.90%, respectively.
Arcturus Therapeutics’s highest amplitude of average volatility was 2.25% (last week), 4.65% (last month), and 3.90% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Arcturus Therapeutics’s stock is considered to be overbought (>=80).
Arcturus Therapeutics’s Stock Yearly Top and Bottom Value
Arcturus Therapeutics’s stock is valued at $33.48 at 18:02 EST, way under its 52-week high of $124.00 and way higher than its 52-week low of $24.87.
Arcturus Therapeutics’s Moving Average
Arcturus Therapeutics’s worth is way under its 50-day moving average of $40.67 and way under its 200-day moving average of $40.29.
More news about Arcturus Therapeutics (ARCT).